Paid Clinical Trials in Fayetteville, AR

As of August 2026, 60 paid clinical trials are recruiting in Fayetteville, Arkansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

59 clinical trials

Dental-Child Interaction Training

for Behavior and Behavior Mechanisms

Sites in Fayetteville +3 more locations

Sponsor: University of Florida

Sex: All·Age: 18 - 99

Code: NCT06138405·Recruiting·Listed Nov 2023

Apply to this trial

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

for Squamous Cell Carcinoma of Head and Neck

Sites in Fayetteville, Springdale +4 more locations

Sponsor: University of Arkansas

Sex: All·Age: 18 - 100

Code: NCT05952934·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for Anatomic Stage I Breast Cancer AJCC v8

Sites in Fayetteville, Springdale +913 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05929768·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for Diffuse Large B-Cell Lymphoma

Sites in Fayetteville, Springdale +81 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05633615·Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

for Castration-Resistant Prostate Carcinoma

Sites in Fayetteville, Springdale +172 more locations

Sponsor: SWOG Cancer Research Network

Sex: Male·Age: 18+

Code: NCT06470243·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial

Physical Activity and Community EmPOWERment Project

for Intellectual Disability

Sites in Fayetteville +1 more location

Sponsor: University of North Carolina, Chapel Hill

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06740162·Recruiting·Listed Dec 2024

Apply to this trial

Telehealth Multi-Component Optional Model (MOM) Study

for Maternal Health

Sites in Fayetteville, Springdale +4 more locations

Sponsor: University of Arkansas

Sex: Female·Age: 18 - 44·Accepts healthy volunteers

Code: NCT06095960·Recruiting·Listed Oct 2023

Apply to this trial

Protein and Polycystic Ovary Syndrome (PCOS)

for Polycystic Ovary Syndrome (PCOS)

2 locations in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: Female·Age: 18 - 50·Accepts healthy volunteers

Code: NCT07158723·Recruiting·Listed Sep 2025

Apply to this trial

Appetite Response to Meals With Different Protein Sources in Women With PCOS

for Polycystic Ovary Syndrome (PCOS)

1 location in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: Female·Age: 18 - 50

Code: NCT07142603·Recruiting·Listed Aug 2025

Apply to this trial

Combining a Smartphone App With Medications to Manage Heavy Drinking

for Alcohol Use Disorder (AUD)

Sites in Fayetteville +14 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 80

Code: NCT06303778·Recruiting·Listed Mar 2024

Apply to this trial

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

for Attention-Deficit/Hyperactivity Disorder

1 location in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT06115603·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Targeting Components of Distress Tolerance

for Distress, Emotional

1 location in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: All·Age: 18+

Code: NCT06570603·Recruiting·Listed Aug 2024

Apply to this trial

Parkinson's Foundation PD GENEration Genetic Registry

for Parkinson's Disease

Sites in Fayetteville +52 more locations

Sponsor: Parkinson's Foundation

Sex: All·Age: 18+

Code: NCT04994015·Recruiting·Listed Aug 2021

Apply to this trial

Time Restricted Feeding, Muscle, and Metabolism

for Overweight

1 location in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: All·Age: 25 - 50·Accepts healthy volunteers

Code: NCT04949451·Recruiting·Listed Jul 2021

Apply to this trial

Protein and Exercise for Postmenopausal Women's Wellbeing

for Postmenopausal

2 locations in Fayetteville

Sponsor: University of Arkansas, Fayetteville

Sex: Female·Age: All ages

Code: NCT06849817·Recruiting·Listed Feb 2025

Apply to this trial

Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

for Glaucoma, Open-Angle

1 location in Fayetteville

Sponsor: Vold Vision P.L.L.C

Sex: All·Age: 45+

Code: NCT05624398·Recruiting·Listed Nov 2022

Apply to this trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Fayetteville +8 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT07181161·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

for Breast Cancer, Early Breast Cancer

Drug: Camizestrant

Sites in Fayetteville +103 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05952557·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Metastatic Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Fayetteville +26 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06417814·Phase 3·Recruiting·Listed May 2024

Apply to this trial